Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial.
Hum Vaccin Immunother
; 17(12): 5475-5486, 2021 12 02.
Article
in En
| MEDLINE
| ID: mdl-34714720
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Influenza Vaccines
/
Influenza, Human
Type of study:
Clinical_trials
Limits:
Adult
/
Humans
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: